Skip to main content
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. — Investor Relations & Filings

Ticker · PMN ISIN · CA74346M1095 LEI · 5299007HZF79F9IAXI53 US Professional, scientific and technical activities
Open in API
Filings indexed 333 across all filing types
Latest filing 2022-07-01 Regulatory Filings
Country CA Canada
Listing US PMN

About ProMIS Neurosciences Inc.

https://www.promisneurosciences.com/

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company focused on the discovery and development of selective antibody therapeutics for neurodegenerative and other misfolded protein diseases. The company leverages a proprietary technology platform to design and generate antibodies that selectively target toxic oligomers, which are key drivers of diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), and multiple system atrophy (MSA). Its lead product candidate, PMN310, is in clinical development for Alzheimer's disease. The company's approach aims to provide effective treatments while potentially reducing side effects associated with less specific therapies.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from a law firm to the SEC responding to comments on a Registration Statement on Form 10 filed by ProMIS Neurosciences Inc. It references amendments to the Registration Statement and responses to SEC staff comments. The document does not contain financial statements or detailed financial data but is a regulatory communication related to a registration filing. It is not the Registration Statement itself, nor an annual or quarterly report, but a regulatory filing correspondence. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (3440 characters), consistent with a letter rather than a full report.
2022-07-01 English
10-12B/A
Regulatory Filings Classification · 95% confidence The document is titled as an Amendment No. 2 to Form 10, which is a general form for registration of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes detailed sections such as business description, risk factors, financial information, directors and executive officers, executive compensation, legal proceedings, and financial statements. The presence of comprehensive business and financial information, risk factors, and financial statements indicates this is a full registration statement filing rather than a simple announcement or certification. The document is not a quarterly or interim report, nor is it a proxy statement or a call transcript. It is a regulatory filing related to securities registration, which is distinct from an annual report (10-K) or quarterly report (10-Q). Given the nature of the Form 10 and its amendments, this filing is best classified under Regulatory Filings (RNS) as it does not fit the other specific categories such as Annual Report or Interim Report. The document is substantive and lengthy (15,000 characters), so it is not a mere announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-07-01 English
Regulatory Filings 2022
Regulatory Filings
2022-07-01 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing mostly non-readable characters and no discernible financial, regulatory, or corporate information. There are no clear references to any report titles, fiscal periods, regulatory bodies, or keywords that would indicate a specific filing type. The document length is 15,000 characters, which is substantial, but the content does not contain meaningful text to classify as a financial or corporate report. Given the lack of identifiable content and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific categories.
2022-07-01 English
10-12B/A
Regulatory Filings Classification · 95% confidence The document is titled as an Amendment No. 1 to Form 10, which is a general form for registration of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes detailed sections such as business description, risk factors, financial information, properties, security ownership, directors and executive officers, executive compensation, legal proceedings, and financial statements. The presence of comprehensive business and financial information, risk factors, and detailed disclosures indicates this is a full registration statement filing rather than a simple announcement or certification. The document is not a quarterly or interim report, nor is it a proxy statement or a call transcript. It is a regulatory filing related to securities registration, which is a specific type of SEC filing but does not fit the definitions of Annual Report (10-K), Interim Report (10-Q), or other categories. Given the nature of the Form 10 and its amendment, this filing is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories. Confidence is high due to the clear identification of the form and content.
2022-06-30 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel responding to comments from the SEC staff regarding an Amendment No. 1 to a Draft Registration Statement on Form 10. It references the Draft Registration Statement and the Public Registration Statement on Form 10, which is a registration document filed with the SEC. The letter addresses specific SEC comments and the company's responses, indicating it is part of the regulatory review process. The document is short (4106 characters) and primarily a correspondence letter rather than the actual registration statement or financial report. It does not contain financial data or the full report itself but is a regulatory filing related to the registration process. Therefore, it fits best under Regulatory Filings (RNS) as a response to SEC comments and not as the registration statement itself or an annual report.
2022-06-22 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.